Delivery Order SPE2DB20D2001-SPE2DB23FM31X

Award Date 12/7/22
Potential Completion Date 12/8/22
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,203,910 units of sucralfate 1 gram tablets. The contract has a fixed-price, delivery order structure with a ceiling value of $5,352.11 and a completion date of January 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,728.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Sucralfate 1 GM/10 ML suspension medication in 420 ML bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,012.97, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,929.45 firm fixed price delivery order is for the supply of 420 ml bottles of 1 gram/10 ml sucralfate suspension. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
This federal contract award, valued at $6,470.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, designated as a Delivery Order under an Indefinite Delivery Contract (IDC), covers the supply of 4,566,760,172 units of Sucralfate 1 GM Tablet 90S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. This award is part of Amerisourcebergen's...
This federal contract award, valued at $3,590.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. No set-aside designation was used for this contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $8,368.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,826.24, is for the delivery of 90-count bottles of 1 gram Sucralfate tablets, a medication used to treat and prevent certain types of ulcers. The contract is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $1,239.18 firm fixed-price delivery order is for the supply of 4,560,242,783 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has an ultimate completion date of March 14, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,604.04, is a delivery order for the supply of Sucralfate 1 GM/10 ML Suspension for a period ending on December 31, 2024. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not reference...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB23FM31X
    Delivery Order

This federal contract award for $1,659.41 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,559,304,338 units of sucralfate 1 gram/10 milliliter suspension in 420 milliliter containers. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which runs through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:27 AM